Single-tube PCR coupled with mini-sequencing assay for the detection of cyp51A and cyp51B polymorphisms in Aspergillus fumigatus

Feasibility of mini-sequencing schemes based on nucleotide polymorphisms for microbial identification and population analyses

(2015) Ricardo Araujo et al.   APPLIED MICROBIOLOGY AND BIOTECHNOLOGY

Feasibility of mitochondrial single nucleotide polymorphisms to detect and identify Aspergillus fumigatus in clinical samples

(2014) Manuela Oliveira et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

The cdr1B efflux transporter is associated with non-cyp51a-mediated itraconazole resistance in Aspergillus fumigatus 

(2013) Marcin G. Fraczek et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Major variations inAspergillus fumigatusarising within aspergillomas in chronic pulmonary aspergillosis

(2013) S. J. Howard et al.   MYCOSES

SNaPAfu: A Novel Single Nucleotide Polymorphism Multiplex Assay for Aspergillus fumigatus Direct Detection, Identification and Genotyping in Clinical Specimens

(2013) Rita Caramalho et al.   PLoS One

Development of Novel PCR Assays To Detect Azole Resistance-Mediating Mutations of theAspergillus fumigatus cyp51AGene in Primary Clinical Samples from Neutropenic Patients

(2012) Birgit Spiess et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

A tale of three next generation sequencing platforms: comparison of Ion torrent, pacific biosciences and illumina MiSeq sequencers

(2012) Michael Quail et al.   BMC GENOMICS

In vitro–in vivo correlation of voriconazole resistance due to G448S mutation (cyp51A gene) in Aspergillus fumigatus

(2012) S. Krishnan Natesan et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

High prevalence of triazole resistance in Aspergillus fumigatus, especially mediated by TR/L98H, in a French cohort of patients with cystic fibrosis

(2012) F. Morio et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Aspergillus fumigatus Strains with Mutations in thecyp51AGene Do Not Always Show Phenotypic Resistance to Itraconazole, Voriconazole, or Posaconazole

(2011) Pilar Escribano et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

An Improved Model of the Aspergillus fumigatus CYP51A Protein

(2011) M. G. Fraczek et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Rapid Induction of Multiple Resistance Mechanisms in Aspergillus fumigatus during Azole Therapy: a Case Study and Review of the Literature

(2011) Simone M. T. Camps et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Azole Resistance in Aspergillus fumigatus Isolates from the ARTEMIS Global Surveillance Study Is Primarily Due to the TR/L98H Mutation in thecyp51AGene

(2011) Shawn R. Lockhart et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Identification and correction of systematic error in high-throughput sequence data

(2011) Frazer Meacham et al.   BMC BIOINFORMATICS

High-frequency Triazole Resistance Found In Nonculturable Aspergillus fumigatus from Lungs of Patients with Chronic Fungal Disease

(2011) David W. Denning et al.   CLINICAL INFECTIOUS DISEASES

Isolation of multiple-triazole-resistant Aspergillus fumigatus strains carrying the TR/L98H mutations in the cyp51A gene in India

(2011) A. Chowdhary et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3—2009 Update

(2010) J Maertens et al.   BONE MARROW TRANSPLANTATION

SNP discovery performance of two second-generation sequencing platforms in the NOD2 gene region

(2010) Espen Melum et al.   HUMAN MUTATION

Susceptibility to five antifungals of Aspergillus fumigatus strains isolated from chronically colonised cystic fibrosis patients receiving azole therapy

(2010) Adelina Amorim et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Novel mixed-format real-time PCR assay to detect mutations conferring resistance to triazoles in Aspergillus fumigatus and prevalence of multi-triazole resistance among clinical isolates in the Netherlands

(2010) C. H. W. Klaassen et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Genetic diversity ofAspergillus fumigatusin indoor hospital environments

(2010) Ricardo Araujo et al.   MEDICAL MYCOLOGY

Efficacy of Posaconazole against Three Clinical Aspergillus fumigatus Isolates with Mutations in the cyp51A Gene

(2009) E. Mavridou et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Possible Environmental Origin of Resistance of Aspergillus fumigatus to Medical Triazoles

(2009) E. Snelders et al.   APPLIED AND ENVIRONMENTAL MICROBIOLOGY

Simple and highly discriminatory microsatellite-based multiplex PCR for Aspergillus fumigatus strain typing

(2009) R. Araujo et al.   CLINICAL MICROBIOLOGY AND INFECTION

Azole-resistance in Aspergillus: Proposed nomenclature and breakpoints

(2009) Paul E. Verweij et al.   DRUG RESISTANCE UPDATES

Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America

(2008) Thomas J. Walsh et al.   CLINICAL INFECTIOUS DISEASES

Rapid method for testing the susceptibility of Aspergillus fumigatus to amphotericin B, itraconazole, voriconazole and posaconazole by assessment of oxygen consumption

(2008) R. Araujo et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Rapid Detection of Triazole Antifungal Resistance in Aspergillus fumigatus

(2008) G. Garcia-Effron et al.   JOURNAL OF CLINICAL MICROBIOLOGY